Sermorelin & GHRP-6 & GHRP-2 Blend (9mg)

CHF 80.75

The Sermorelin, GHRP-2, and GHRP-6 blend is a potent research tool for stimulating growth hormone release via multiple pituitary receptors. Ideal for studying GH peaks, IGF-1 signaling, and synergistic peptide interactions in laboratory models.

Description

Buy Sermorelin GHRP-2 GHRP-6 Blend – Advanced Growth Hormone Research Peptide (Growth hormone peptides for research)

The Sermorelin, GHRP-2, and GHRP-6 peptide blend is a cutting-edge tool for laboratory research focused on growth hormone (GH) stimulation. Designed for studies on pituitary cells (somatotrophs), this triple peptide blend targets multiple receptor pathways, offering a comprehensive approach to investigating GH release.

Sermorelin, a 29-amino acid analog of endogenous GHRH, activates classical GHRH receptors on anterior pituitary cells, triggering intracellular cAMP and PKA pathways that drive GH synthesis. GHRP-2 and GHRP-6, synthetic hexapeptides, target GHS-R1a receptors (ghrelin-sensitive), activating complementary intracellular cascades involving PLC, IP₃, DAG, and PKC to mobilize GH-containing vesicles.

How the Triple Blend Works

  • Sermorelin GHRP-2 GHRP-6 peptide blend: Stimulates GHRH receptors, promoting sustained GH synthesis and release.
  • GHRP-2: Engages GHS-R1a, producing high-amplitude GH secretory bursts.
  • GHRP-6: Also targets GHS-R1a, supporting rapid GH peaks and downstream IGF-1 signaling.
  • Synergistic Action: Research indicates the combination can enhance GH output beyond individual peptides, demonstrating additive and synergistic effects for lab studies.

Research Insights

  • Sermorelin alone can double 12-hour GH output in pituitary cell models.
  • GHRP-2 exposure may increase GH levels 4–6 fold over baseline, while GHRP-6 can induce peaks more than 3 times typical physiological maxima.
  • When combined, studies suggest the blend may raise GH levels significantly higher than any single peptide, supporting enhanced IGF-1 production.
  • Laboratory findings also suggest that IGF-1 increases by roughly 27–28% with Sermorelin and 50–80% with GHRP-2, indicating strong anabolic signaling potential.

Benefits for Laboratory Research

  • Facilitates dual- and triple-receptor stimulation studies
  • Supports growth hormone and IGF-1 pathway research
  • Provides a tool for investigating synergistic GH secretion
  • Enables exploration of somatotroph function and pituitary signaling

Chemical Profile

Reviews

There are no reviews yet.

Be the first to review “Sermorelin & GHRP-6 & GHRP-2 Blend (9mg)”

Your email address will not be published. Required fields are marked *